Literature DB >> 21906580

Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis.

Michiko Itoh1, Takayoshi Suganami, Nobutaka Nakagawa, Miyako Tanaka, Yukio Yamamoto, Yasutomi Kamei, Shuji Terai, Isao Sakaida, Yoshihiro Ogawa.   

Abstract

Obesity may be viewed as a state of chronic low-grade inflammation that participates in the development of the metabolic syndrome. Nonalcoholic steatohepatitis (NASH) is considered a hepatic phenotype of the metabolic syndrome and a high risk for progression to cirrhosis and hepatocellular carcinoma. Although the "two hit" hypothesis suggests involvement of excessive hepatic lipid accumulation and chronic inflammation, the molecular mechanisms underlying the development of NASH remain unclear, in part because of lack of appropriate animal models. Herein we report that melanocortin 4 receptor-deficient mice (MC4R-KO) develop steatohepatitis when fed a high-fat diet, which is associated with obesity, insulin resistance, and dyslipidemia. Histologic analysis reveals inflammatory cell infiltration, hepatocyte ballooning, and pericellular fibrosis in the liver in MC4R-KO mice. Of note, all of the MC4R-KO mice examined developed well-differentiated hepatocellular carcinoma after being fed a high-fat diet for 1 year. They also demonstrated enhanced adipose tissue inflammation, ie, increased macrophage infiltration and fibrotic changes, which may contribute to excessive lipid accumulation and enhanced fibrosis in the liver. Thus, MC4R-KO mice provide a novel mouse model of NASH with which to investigate the sequence of events that make up diet-induced hepatic steatosis, liver fibrosis, and hepatocellular carcinoma and to aid in understanding the pathogenesis of NASH, pursuing specific biomarkers, and evaluating potential therapeutic strategies.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21906580      PMCID: PMC3204024          DOI: 10.1016/j.ajpath.2011.07.014

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

Review 1.  From fat to inflammation.

Authors:  Christopher Paul Day
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

2.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

3.  Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model.

Authors:  Kazuhisa Kondo; Rei Shibata; Kazumasa Unno; Masayuki Shimano; Masakazu Ishii; Tetsutaro Kito; Satoshi Shintani; Kenneth Walsh; Noriyuki Ouchi; Toyoaki Murohara
Journal:  Circ Cardiovasc Interv       Date:  2010-03-23       Impact factor: 6.546

4.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha.

Authors:  Takayoshi Suganami; Junko Nishida; Yoshihiro Ogawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

6.  Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.

Authors:  Yasuo Horie; Akira Suzuki; Ei Kataoka; Takehiko Sasaki; Koichi Hamada; Junko Sasaki; Katsunori Mizuno; Go Hasegawa; Hiroyuki Kishimoto; Masahiro Iizuka; Makoto Naito; Katsuhiko Enomoto; Sumio Watanabe; Tak Wah Mak; Toru Nakano
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

7.  Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.

Authors:  Yoshihiro Kamada; Hitoshi Matsumoto; Shinji Tamura; Juichi Fukushima; Shinichi Kiso; Koji Fukui; Takumi Igura; Norikazu Maeda; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa; Iichiro Shimomura; Norio Hayashi
Journal:  J Hepatol       Date:  2007-04-09       Impact factor: 25.083

8.  Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects.

Authors:  Michiko Itoh; Takayoshi Suganami; Noriko Satoh; Kanami Tanimoto-Koyama; Xunmei Yuan; Miyako Tanaka; Hiroyuki Kawano; Takashi Yano; Seiichiro Aoe; Motohiro Takeya; Akira Shimatsu; Hideshi Kuzuya; Yasutomi Kamei; Yoshihiro Ogawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-06-14       Impact factor: 8.311

9.  Blockade of CCR2 ameliorates progressive fibrosis in kidney.

Authors:  Kiyoki Kitagawa; Takashi Wada; Kengo Furuichi; Hiroyuki Hashimoto; Yoshiro Ishiwata; Masahide Asano; Motohiro Takeya; William A Kuziel; Kouji Matsushima; Naofumi Mukaida; Hitoshi Yokoyama
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

10.  Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?

Authors:  Siobhán E McQuaid; Leanne Hodson; Matthew J Neville; A Louise Dennis; Jane Cheeseman; Sandy M Humphreys; Toralph Ruge; Marjorie Gilbert; Barbara A Fielding; Keith N Frayn; Fredrik Karpe
Journal:  Diabetes       Date:  2010-10-13       Impact factor: 9.461

View more
  66 in total

1.  Mouse Models of Liver Fibrosis.

Authors:  Aashreya Ravichandra; Robert F Schwabe
Journal:  Methods Mol Biol       Date:  2021

2.  Late onset obesity in mice with targeted deletion of potassium inward rectifier Kir7.1 from cells expressing the melanocortin-4 receptor.

Authors:  Erica J P Anderson; Masoud Ghamari-Langroudi; Isin Cakir; Michael J Litt; Valerie Chen; Roman E Reggiardo; Glenn L Millhauser; Roger D Cone
Journal:  J Neuroendocrinol       Date:  2019-01-20       Impact factor: 3.627

Review 3.  Aggressive Crosstalk Between Fatty Acids and Inflammation in Macrophages and Their Influence on Metabolic Homeostasis.

Authors:  Kazuhiro Nishiyama; Yasuyuki Fujimoto; Tadayoshi Takeuchi; Yasu-Taka Azuma
Journal:  Neurochem Res       Date:  2017-04-19       Impact factor: 3.996

4.  CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis.

Authors:  Michiko Itoh; Takayoshi Suganami; Hideaki Kato; Sayaka Kanai; Ibuki Shirakawa; Takeru Sakai; Toshihiro Goto; Masahiro Asakawa; Isao Hidaka; Hiroshi Sakugawa; Koji Ohnishi; Yoshihiro Komohara; Kenichi Asano; Isao Sakaida; Masato Tanaka; Yoshihiro Ogawa
Journal:  JCI Insight       Date:  2017-11-16

5.  Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH.

Authors:  George N Ioannou; Derrick M Van Rooyen; Christopher Savard; W Geoffrey Haigh; Matthew M Yeh; Narci C Teoh; Geoffrey C Farrell
Journal:  J Lipid Res       Date:  2014-12-17       Impact factor: 5.922

Review 6.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

Review 7.  Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?

Authors:  David H Ipsen; Jens Lykkesfeldt; Pernille Tveden-Nyborg
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

Review 8.  Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis.

Authors:  Hayato Nakagawa
Journal:  World J Hepatol       Date:  2015-08-18

9.  Inhibition of the central melanocortin system decreases brown adipose tissue activity.

Authors:  Sander Kooijman; Mariëtte R Boon; Edwin T Parlevliet; Janine J Geerling; Vera van de Pol; Johannes A Romijn; Louis M Havekes; Illiana Meurs; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2014-07-12       Impact factor: 5.922

10.  Vitamin E does not prevent Western diet-induced NASH progression and increases metabolic flux dysregulation in mice.

Authors:  Clinton M Hasenour; Arion J Kennedy; Tomasz Bednarski; Irina A Trenary; Brandon J Eudy; Robin P da Silva; Kelli L Boyd; Jamey D Young
Journal:  J Lipid Res       Date:  2020-02-21       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.